Literature DB >> 8217186

Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues.

R I Garver1, C S Chan, P G Milner.   

Abstract

Abundant evidence suggests that growth factors are important mediators of non-small cell lung cancer (NSCLC) growth. Although multiple growth factors have been found to be produced by NSCLC tissues, little is known about possible differences in growth factor expression between malignant and adjacent normal lung tissues. Variation in growth factor expression between normal and malignant lung tissues could be potentially useful diagnostically and therapeutically. In studies reported here, the expression of the angiogenic growth factor pleiotrophin (PTN) and homolog midkine (MK) was assessed in resected normal and malignant lung tissues. Primers specific for the two growth factors were used to amplify reverse transcriptase-produced DNA copies of RNA transcripts harvested from the tissues. This analysis revealed that all normal lung tissues examined (n = 17) expressed PTN but only two expressed MK. Conversely, all of the resected lung cancers (n = 20) expressed MK but only one expressed PTN. These results demonstrated a striking reciprocal expression pattern of MK and PTN in normal versus malignant lung tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217186     DOI: 10.1165/ajrcmb/9.5.463

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  30 in total

1.  Promotion of self-renewal of embryonic stem cells by midkine.

Authors:  Xing Yao; Zhou Tan; Bin Gu; Rong-rong Wu; Yu-kan Liu; Li-cheng Dai; Ming Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-05       Impact factor: 6.150

2.  Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.

Authors:  Mine Erguven; Ayhan Bilir; Nuray Yazihan; Seval Korkmaz; Esin Aktas; Cem Ovalioglu; Tolga Dundar; Hakan Seyithanoglu
Journal:  Oncol Lett       Date:  2011-10-04       Impact factor: 2.967

3.  Expression of the heparin-binding growth factors Midkine and pleiotrophin during ocular development.

Authors:  Ruda Cui; Peter Lwigale
Journal:  Gene Expr Patterns       Date:  2019-02-27       Impact factor: 1.224

4.  Expression and purification of bioactive high-purity human midkine in Escherichia coli.

Authors:  Zhong-hui Zhang; Li-juan Du; Di Xiang; Shun-ying Zhu; Ming-yuan Wu; Hui-li Lu; Yan Yu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

5.  Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.

Authors:  Zhihong Ma; Hongwei Li; Bin Wang; Qibin Shen; Enhai Cui; Lishan Min; Fuchu Qian; Jinliang Ping; Licheng Dai
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-07       Impact factor: 4.553

Review 6.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

7.  Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.

Authors:  M Takagi-Kimura; T Yamano; M Tagawa; S Kubo
Journal:  Cancer Gene Ther       Date:  2014-02-28       Impact factor: 5.987

8.  Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis.

Authors:  Li-Cheng Dai; Xiang Wang; Xing Yao; Yong-Liang Lu; Jin-Liang Ping; Jian-Fang He
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

9.  Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.

Authors:  Misato Takagi-Kimura; Tomoki Yamano; Atsuko Tamamoto; Nobutaka Okamura; Haruki Okamura; Tomoko Hashimoto-Tamaoki; Masatoshi Tagawa; Noriyuki Kasahara; Shuji Kubo
Journal:  Cancer Sci       Date:  2013-09-23       Impact factor: 6.716

10.  Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinoma.

Authors:  Li-Cheng Dai; Xiang Wang; Xing Yao; Yong-Liang Lu; Jin-Liang Ping; Jian-Fang He
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.